AKT1 and differentiated thyroid carcinoma: Liu et al., indicated that the low expression of NEAT1 could affect the radioactive iodine resistance by the miR-101-3p/FN1/PI3K-AKT signaling pathway in papillary thyroid carcinoma cells (Liu et al., 2019).